Member access

4-Traders Homepage  >  Shares  >  Swiss Exchange  >  Newron Pharmaceuticals SpA    NWRN   IT0004147952

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Newron Pharmaceuticals SpA
Discovers and develops small molecule drugs

Newron Pharmaceuticals SpA engages in the research and development of therapies for patients with diseases of the Central Nervous System and pain.

The focus of its treatments includes patients with Parkinson's disease, Rett Syndrome, Amyotrophic Lateral Sclerosis, schizoprenia, and neuropathic pain.

The company was founded by Luca Benatti, Ruggero Fariello, and Patricia Salvati in 1999 and is headquartered in Bresso, Italy.

Number of employees : 23 persons.
Sales per Businesses
20132014Delta
CHF (in Million)%CHF (in Million)%
Pharmaceutical Drugs3.95100%1.58100% -150.52%
Sales per Regions
20132014Delta
CHF (in Million)%CHF (in Million)%
Global3.95100%1.58100% -150.52%
Managers
NameAgeSinceTitle
Stefan Weber502005Chief Executive Officer, MD, Director & IR Contact
Ulrich Köstlin, PhD632013Non-Executive Chairman
Roberto Galli-2002VP-Finance & Investor Relations Contact
Ravi Anand, MD582005Chief Medical Officer
Patrick J. Langlois, PhD692008Independent Director
Hanns Moehler, MD-2008Non-Executive Director
Roberto Consonni-2012Non-Executive Director
Robert Leslie Holland MD, PhD602013Non-Executive Director
Bo Jesper Hansen MD, PhD572013Non-Executive Director
Marco Caremi582002Executive Vice President-Business Development
Shareholders
NameShares%
Investor AB 1,665,733 12.7%
Gefim SpA 1,484,195 11.3%
JPMorgan Asset Management (UK) Ltd. 386,679 2.95%
Swisscanto Asset Management AG 153,705 1.17%
Polar Capital LLP 133,938 1.02%
Aviva Investors Global Services Ltd. 115,695 0.88%
Credit Suisse AG 68,962 0.53%
UBS AG (Investment Management) 62,720 0.48%
Michel & Cortesi Asset Management AG 53,214 0.41%
Pictet Asset Management SA 27,959 0.21%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
ACTELION LTD
SHANGHAI RAAS BLO..
-
MEDIVATION INC
INTERCEPT PHARMAC..
HUALAN BIOLOGICAL..
TONGHUA DONGBAO P..
BLUEBIRD BIO INC
BEIJING SL PHARMA..
RECEPTOS INC
GENMAB A/S
ZHONGYUAN UNION C..
-
AGIOS PHARMACEUTI..
JUNO THERAPEUTICS..
-
DYAX CORP.
NEUROCRINE BIOSCI..
CLOVIS ONCOLOGY I..
ULTRAGENYX PHARMA..
-
CHINA BIOLOGIC PR..
COSMO PHARMACEUTI..
-
GW PHARMACEUTICAL..
-
Sector Biotechnology & Medical Research
Newron Pharmaceuticals SpA : Connections
PJL Consulting
Oxford Gene Technology IP Ltd.
DFC Langlois
Axxam SpA
Constantia Flexibles Group GmbH
Early Clinical Development Consulting Ltd.
European School of Management & Technology GmbH
Z-Cube SRL
CMC Contrast AB
Italia Assistenza SpA
Orphazyme ApS
Universitätsklinikum Würzburg
Constantia Flexibles AG
Karolinska Development AB (Private Equity)
AGY Therapeutics, Inc.
Swiss National Center of Neuroscience Research
Swiss Federal Institute of Technology
Zymenex A/S
European Academy of Sciences
MipSalus ApS
Swiss Academy of Medical Sciences
Gambro AB
Company contact information
Newron Pharmaceuticals SpA
via Ludovico Ariosto 21
Bresso, Milan 20091

Phone : +39.02.610.3461
Fax : +39.02.610.34654
Web : www.newron.com
© 2015 People , Fundamentals and Ownership